Kaihanga parakore teitei CAS 1197-18-8 Waikawa Tranexamic
Ko te waikawa tranexamic, e kiia ana ko te waikawa tranexamic, he whakaputanga waihanga o te lysine he rite te hanganga ki te tyrosine. I whakamanahia e nga whakamatautau haumanu, he pai mo nga momo kiri katoa, ka taea te tango i te kiri, te ma, me te whakamarama i nga waahi, penei i te: te paheketanga i muri i te ra o te ra, nga wahi pouri (chloasma, freckles, senile lentils, etc.), kiri tairongo, hakihaki. me te mumura, te tiaki i muri i te mahi i muri i te taiaho, te maimoatanga marama puhoi, me etahi atu.
Ko te waikawa tranexamic he rongoa antifibrinolytic waikawa amino waihanga ka taea te aukati i te herenga o te lysine i roto i te fibrin ki te plasmin, na reira ka aukati i te lysis o nga kopa fibrin me te whakaputa hemostasis. Kei te nuinga whakamahia te reira haumanu. Mo nga momo momo whakaheke toto na te hyperfibrinolysis.
Nga tono waikawa tranexamic
![1197-18-8 WHAKARANGAw5m](https://ecdn6.globalso.com/upload/p/689/image_other/2024-04/661c8cfa6c37418417.png)
1. Ko te waikawa tranexamic he rongoa anti-fibrinolytic, ka taea e ia te rongoa i nga momo toto whakapeka me te mau tonu me te whakatutuki i te hemostasis.
2.Ka taea e te waikawa Tranexamic te whakaheke i te hanga melanin: Ka taea e ia te whakataetae tika ki te tyrosine i roto i nga pūtau, te aukati i te hua o te mate o te tyrosine, me te whakaheke i te hanga melanin.
![CAS 1197-18-8txb](https://ecdn6.globalso.com/upload/p/689/image_other/2024-04/661c8d06296aa28089.png)
3. Aukati i te angiogenesis: Ka taea e ia te whakataetae tika ki te tyrosine i roto i nga pūtau, te aukati i te paanga catalytic o te tyrosine metabolism, me te aukati i te angiogenesis kiri. Ka taea e tenei te whakaiti i te maha o nga oko toto i roto me te huri noa i nga whiu chloasma, ka whakaiti i te puta o nga tauhohenga mumura, me te whakaiti i te hanganga tonu o te chloasma.
4.Ka taea e te waikawa tranexamic te whakaiti i te whakapuakitanga o nga cytokines pro-inflammatory me chemokines ki te whakaputa i nga paanga anti-inflammatory, ka taea te aukati i te puta o nga tauhohenga mate me te whakaiti i te hanganga o te hakihaki.
![Waikawa Tranexamicxdg](https://ecdn6.globalso.com/upload/p/689/image_other/2024-04/661c8d0fd0dab42839.png)
5. Ko te waikawa Tranexamic he taonga Anti-aging me te anti-photoaging. Ka whakanui ake i te whakahiato waikawa hyaluronic ma te whakanui ake i te maha o nga pūtau epidermal, ka whakaheke i te whakahekenga o te matrix extracellular i roto i nga dermis ma te aukati i te plasmin, a ka taea te whakaiti i nga taumata o etahi matū oxidative i roto i te toto hei whakapai ake i te tawhito o te kiri. Te whakapai ake i te whakaahua whakaahua a te UVB ma te whakanui ake i te biogenesis mitochondrial, te whakarite i te hunanga o te homoni ma te whakanui ake i te whakapuakitanga o nga kaiwhakawhiwhi o te estrogen i runga i te mata o nga pūtau mast, me te whakapai ake i te whakaahua whakaahua a UVA.
Waikawa Tranexamic Whakatakotoranga
Hebei WeiBang Biotechnology Co., Ltd
Ingoa Hua | Te waikawa tranexamic | CAS No | 1197-18-8 |
Te Ra Whakaputa | 2023/12/01 | Rā Pūrongo | 2023/12/01 |
Te nui | 10,000KG | Te Ra Whakamatau | 2023/12/01 |
PukaNo | WB20231201 | Te ora papa | 2 tau |
Nga Tuemi Whakamatau | Whakatakotoranga | ||
Te ahua | Te paura tioata ma | ||
Tautuhinga | ME | ||
Ngaronga i te whakamaroke | ≤0.50% | ||
pH | 7.0-8.0 | ||
Te whakamatautau | ≥99.0 | ||
Te pungarehu ngongo | ≤0.10% | ||
Matū whai pānga | poke A: ≤0.10% | ||
poke B: ≤0.20% | |||
Tetahi atu poke: ≤0.10% | |||
Ko etahi atu poke katoa: ≤0.20% | |||
pūhaumāota | ≤140ppm | ||
Tatau pereti tapeke | ≤1000cfu/g | ||
Te rewena me te pokepoke | ≤100cfu/g | ||
Pb | ≤10mg/kg | ||
As | ≤2mg/kg | ||
Hg | ≤1mg/kg | ||
Cd | ≤5mg/kg | ||
Whakamutunga | Kua whai tohu |